Towards a simple, saliva-based test for the detection of oral cancer. 'Oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'

Expert Review of Molecular Diagnostics

Volumn 6, Issue 3, 2006, Pages 267-272

  Wong, David T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; SALIVA PROTEIN; TUMOR MARKER;

CANCER MORTALITY; CANCER SURVIVAL; DNA CONTENT; EDITORIAL; HEALTH STATUS; HUMAN; MOUTH CANCER; QUALITY OF LIFE; SALIVA ANALYSIS; SCREENING; TREATMENT OUTCOME; DIAGNOSTIC PROCEDURE; GENETIC PROCEDURES; METABOLISM; METHODOLOGY; MOUTH DISEASE; MOUTH TUMOR; NANOTECHNOLOGY; PROTEIN SYNTHESIS; PROTEOMICS; SALIVA;

BIOSENSING TECHNIQUES; DIAGNOSIS, ORAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOUTH NEOPLASMS; NANOTECHNOLOGY; PROTEIN BIOSYNTHESIS; PROTEOMICS; SALIVA; SALIVARY PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745948559     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.3.267     Document Type: Editorial

References (41)

1. Schantz SP. Carcinogenesis, markers, staging, and prognosis of head and neck cancer. Curr. Opin. Oncol. 5(3), 483-490 (1993).
2. Schantz SP. Biologic markers, cellular differentiation, and metastatic head and neck cancer. Eur. Arch. Otorhinolaryngol. 250(8), 424-428 (1993).
3. Ferlito A, Shaha AR, Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 38(1), 3-5 (2002).
4. Epstein JB, Zhang, L, Rosin, M. Advances in the diagnosis of oral premalignant and malignant lesions. J. Can. Dent. Assoc. 68(10), 617-621 (2002).
5. Fong K, Srivastava S, Gopal-Srivastava R, Kramer B et al. Molecular genetic basis for early cancer detection and cancer susceptibility. Mol. Pathol. Early Cancer 13-26 (1999).
6. Myers L, Wax M. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J. Otolaryngol. 27(6), 342-347 (1998).
7. Zhang L, Williams M, Poh CF et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 65(17), 8017-8021 (2005).
8. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J. Clin. 45(6), 328-351 (1995).
9. Rosin MP, Cheng X, Poh C et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin. Cancer Res. 6(2), 357-362 (2000).
10. Erber R, Conradt C, Homann N et al. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 16(13), 1671-1679 (1998).
11. Gleich LL, Wang J, Gluckman JL, Fenoglio-Preiser CM. Microsatellite instability as a predictor of survival in head and neck cancer - is there a link with colon cancer? ORL J. Otorhinolaryngol. Relat. Spec. 65(4), 193-198 (2003).
12. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79(3), 595-604 1997).
13. Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T, Sasagawa T. Association of Epstein-Barr virus with oral cancers. Hum. Pathol. 33(6), 608-614 (2002).
14. Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK, Lotan R. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 4(8), 871-876 (1995).
15. Nagler R. Oral cancer - molecular aberrations and tumor markers cellular aberrations. Harefuah 142(4), 272-276, 318, 317 (2003).
16. Sidransky D. Emerging molecular markers of cancer. Nature Rev. Cancer 3, 210-219 (2002).
17. Ishwad CS, Ferrell RE, Rossie KM et al. Microsatellite instability in oral cancer. Int. J. Cancer 64(5), 332-335 (1995).
18. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol. 36(6), 525-528 (2000).
19. Shin KH, Park KH, Hong HJ et al. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients. Int. J. Oncol. 21(2), 297-302 (2002).
20. Liao PH, Chang YC, Huang MF, Tai KW, Chou MY. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol. 36(3), 272-276 (2000).
21. El-Naggar AK, Mao L, Staerkel G et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J. Mol. Diagn. 3(4), 164-170 (2001).
22. Jiang WW, Masayesva B, Zahurak M et al. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin. Cancer Res. 11(7), 2486-2491 (2005).
23. Zhao M, Rosenbaum E, Carvalho AL et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int. J. Cancer 117(4), 605-610 (2005).
24. Phillips C. Rinse and spit: saliva as a cancer biomarker source. In: NCI Cancer Bulletin, 3-5 (2006).
25. Hu S, Xie Y, Ramachandran P et al. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5(6), 1714-1728 (2005).
26. Hu S, Denny P, Denny P et al. Differentially expressed protein markers in human submandibular and sublingual secretions. Int. J. Oncol. 25(5), 1423-1430 (2004).
27. Alevizos I, Mahadevappa M, Zhang X et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20(43), 6196-6204 (2001).
28. St John M, Li Y, Zhou X et al. IL-6 and IL-8: potential biomarkers for oral cavity and oropharyngeal SCCA. Arch. Otolaryngol. Head Neck Surg. 130, 929-935 (2004).
29. Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J. Dent. Res. 83(3), 199-203 (2004).
30. Li Y, St John MA, Zhou X et al. Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 10(24), 8442-8450 (2004).
31. Li Y, Elashoff D, Oh M et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J. Clin. Oncol. 24(11), 1754-1760 (2006).
32. Parry J. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance. Ann. NY Acad. Sci. 694, 216-233 (1993).
33. Nair P, Schroeder, H. Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology 57, 171-180 (1986).
34. Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am. J. Med. 102(Suppl. 4A), 9-14 (1997).
35. Hodinka R, Nagashunmugam, T, Malamud, D. Detection of human immunodeficiency virus antibodies in oral fluids. Clin. Diagn. Lab. Immunol. 5, 419-426 (1998).
36. Sayer R, Law E, Connelly PJ, Breen KC. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors. Clin. Biochem. 37, 98-104 (2004).
37. Streckfus C, Bigler L, Tucci M, Thigpen JT. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 18(2), 101-109 (2000).
38. Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin. Cancer Res. 6(6), 2363-2370 (2000).
39. Pepe MS, Etzioni R, Feng Z et al. Phases of biomarker development for early detection of cancer. J. Natl Cancer Inst. 93(14), 1054-1061 (2001).
40. Park NJ, Li Y, Yu T, Wong DT et al. Characterization of RNA in Saliva. Clin. Chem. (2006) (In Press).
41. The Oral Cancer Foundation www.oralcancerfoundation.org